19 August 2025
In an increasingly digital world, the life science sector has become a prime target for cyberattacks. From biotechnology and pharmaceutical companies to clinical research organisations and healthcare institutions, the industry holds a vast amount of high-value data. These can include intellectual property, patient records, clinical trial results, and proprietary formulas. As life science organisations embrace digitalisation, their exposure to risk grows in parallel.
Why life sciences are a high-value target
Life science organisations operate at the intersection of science, data, and innovation. This makes them particularly attractive to cybercriminals seeking to:
- Steal intellectual property for profit or espionage
- Disrupt critical research operations
- Exploit sensitive personal health data
- Hold systems or data hostage through ransomware attacks
The consequences of business risks can be severe, ranging from financial losses and regulatory fines to reputational damage and delayed product development.
Cybersecurity as a frontline defence
Strong cybersecurity measures are no longer optional. Life science companies must implement:
- Advanced threat detection and response systems
- Secure cloud infrastructure and data encryption
- Regular penetration testing and vulnerability assessments
- Employee training to prevent phishing and insider threats
These measures help prevent breaches, protect sensitive data, and ensure regulatory compliance in an industry governed by strict privacy and data protection laws.
Cyber Insurance: Essential risk mitigation
Even with the best defences, no system is infallible. Cyber insurance provides a crucial safety net, covering financial losses, legal fees, data recovery costs, and business interruption. For life science organisations, it also signals to partners, regulators, and investors that proactive risk management is in place.
A sector that can’t afford downtime
In life sciences, delays or disruptions can mean more than just lost revenue; they can affect patient outcomes, research breakthroughs, and public health. Cybersecurity and cyber insurance are essential components of business continuity, helping ensure that innovation and care continue even in the face of evolving threats.
As cyberattacks grow more sophisticated, life science organisations must stay one step ahead. In this sector, digital safety is vital to scientific integrity and societal trust.
Why choose Verlingue when it comes to cyber insurance in life sciences
Life sciences companies face increasing cyber risks, from ransomware attacks and data breaches to digital supply chain vulnerabilities. Protecting sensitive patient data, safeguarding intellectual property, and maintaining regulatory compliance are critical to business resilience. At Verlingue, we deliver tailored cyber insurance and risk management solutions designed for the unique challenges of pharmaceuticals, biotechnology, medical devices, and healthcare. With our expertise in cybersecurity and life sciences insurance, we help you strengthen digital safety, ensure compliance, and protect innovation.
This information is for general information only. Cover is subject to underwriting, terms, conditions, and exclusions.
